Equity
€14.7m ▲ 15.4%
STERIGENICS BELGIUM (FLEURUS) paid out €4.1m in dividends. That is 68% of the 2025 profit.
STERIGENICS BELGIUM (FLEURUS)
Lifetime
7 annual accounts with figures on one time axis, 35 filings since 1991peak €18.4m (2025)
€18.4m▲ 1.7%
peak €6.5m (2023)
€6.1m▼ 3.9%
peak €21.1m (2023)
€14.7m▲ 15.4%
€1.0m▼ 5.6%
peak 47.5 FTE (2024)
45.7 FTE▼ 3.8%
Board6 names since 2020
2 directorsRITACCIO Giuseppe and 1 other
Owners4 names in the annual accounts
100%NELSON LABS and 1 other
Documentsfilings and deeds
23-07-20268 days before the deadline
2025financial year
1 director appointed, 1 resignation, 1 statutory auditor reap… 09-09Dividend €4.1mEquity from €12.7m to €14.7mCash from €1,051 to €465
Key points
from the 2025 annual accountsGrowth
6 years
6 years of growth in a row. Turnover 2025: €18.4m.
Investments
€3.8m 2.4 × depreciation
Green is investment, beige is depreciation.
Liquidity
5.01 was 2.97 in 2024
Short-term debts fell from €1.0m to €948,638.
Filings
35 annual accounts since 1991
Three of the last ten came late. The 2022 accounts came latest: 58 days after the end of the period.
Position in the sector
€6.1m
Higher net result than 95% of companies in office administrative support. Sector median €49,110 · 1,169 companies.
Checked score
97
Excellent
Financially stronger than 74% of small companies in office administrative support (NACE 82)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.1% across 1,123 companies (NACE 82, small).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.2%
01-2025: 0.2%● unchanged vs 12-2024
02-2025: 0.1%▼ -0.1 percentage points vs 01-2025
03-2025: 0.1%● unchanged vs 02-2025
04-2025: 0.1%● unchanged vs 03-2025
05-2025: 0.1%● unchanged vs 04-2025
06-2025: 0.2%▲ +0.1 percentage points vs 05-2025
07-2025: 0.2%● unchanged vs 06-2025highest value
08-2025: 0.2%● unchanged vs 07-2025
09-2025: 0.2%● unchanged vs 08-2025
10-2025: 0.2%● unchanged vs 09-2025
11-2025: 0.2%● unchanged vs 10-2025
12-2025: 0.2%● unchanged vs 11-2025
01-2026: 0.2%● unchanged vs 12-2025
02-2026: 0.1%▼ -0.1 percentage points vs 01-2026
03-2026: 0.1%● unchanged vs 02-2026
04-2026: 0.1%● unchanged vs 03-2026
05-2026: 0.1%● unchanged vs 04-2026
06-2026: 0.2%▲ +0.1 percentage points vs 05-2026
07-2026: 0.2%● unchanged vs 06-2026
08-2026: 0.1%▼ -0.1 percentage points vs 07-2026lowest value
09-2026: 0.1%● unchanged vs 08-2026lowest value
10-2026: 0.1%● unchanged vs 09-2026
11-2026: 0.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
raises risk
Liquidity: current ratio 5.01, cash €465, halved
lowers risk
Founded in 1990
Profit of €6.1m (financial year 2025)
Size: turnover €18.4m, 45.7 FTE, total assets €16.4m
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 82, small). It does better than 89% of them on solvency, 47% on liquidity, 97% on profitability and 62% on growth.
The bankruptcy probability was computed on 08-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 20,137 companies had the same profile as STERIGENICS BELGIUM (FLEURUS) has now. Each dot stands for 51 companies, two years later.
95.1%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
That fits the bankruptcy probability of STERIGENICS BELGIUM (FLEURUS) itself: 0.1% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 20,137 companies, not a prediction for STERIGENICS BELGIUM (FLEURUS). The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €1,400,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 5.01 (2.97 in 2024), above the usual 1.5. Short-term debt is 5.8% and cash 0% of total assets. 10.5% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-07-2026, 8 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
8 days early
2024
24 days early
2023
30 days late
2022
58 days late
2021
4 days early
2020
3 days early
2019
on the day
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 7 days after the deadline. In the sector (NACE 82), the median for financial year 2024 was 7 days before the deadline, and 35% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 27 July (4 of the last 5 accounts filed within 35 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
09-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
- NELSON LABS 100%score 95equity €595.3m (2025) · annual accounts 2025
Recent changes
2 directors appointed, 2 resignations
Resignations: VAN DEN BERGH Robin Pieter Julia and RITACCIO Giuseppe · Appointments: VAN DEN BERGH Robin Pieter Julia and RITACCIO Giuseppe · Legal-form conversion: from public limited company to private limited company · General meeting of 23-07-2026 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0442042064
1 director appointed, 1 resignation, 1 statutory auditor reappointed
Resignation: Lars Ründstrom · Appointment: Robin Van Den Bergh · Reappointment: EY Bedrijfsrevisoren BV (statutory auditor) · General meeting of 30-07-2025 · Gazette deed
Permanent representatives: Piet Hemschoote and Han Wevers
General meeting of 26-11-2024 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| STERIGENICS BELGIUM (FLEURUS) Fleurus | €18.4m | 44.0% | 89.5% | 45.7 |
| FRESH CONCEPT Charleroi | €22.2m | 1.9% | 15.5% | 44.3 |
| BELFRESCA Sint-Katelijne-Waver | €14.8m | 10.1% | 22.0% | 35.8 |
| BAKBEL EUROPE Seneffe | €20.3m | 8.0% | 52.9% | 41 |
| INTERCAN Hemiksem | €44.0m | 2.3% | 7.4% | 35.3 |
| BRABOPAK Wommelgem | €17.9m | 4.2% | 70.1% | 21.4 |
| DARCOPACK Wevelgem | €30.4m | 3.2% | 59.1% | 19.5 |
Grey: the largest companies of the sector (office administrative support (NACE 82)), without their names. Blue: the sector peers from the table.
These companies have the same main activity as STERIGENICS BELGIUM (FLEURUS): office administrative, office support and other business support activities (NACE 82920). They are comparable in size and age: total assets between €7.1m and €14m, founded between 1986 and 2005.
Official details
Source: KBO- Status
- Active since 26-11-1990Normal situation
- Activity
- Office administrative, office support and other business support activitiesNACE 82920and 1 other
- Joint committees
- 116Chemical industry
- 207White-collar workers in the chemical industry · annual accounts 2025
- Establishment unit
- 2.050.604.0516220 Fleurus, since 12-12-1990
- Financial year end
- 31 December
- Peppol
- Reachable since 02-01-2026
Annual accounts 2025
- €16.4m▲ 13.1%
- Employeeson 31-12-2025
- 45▼ 4.3%
- Filing
- Filed on 23-07-2026, 8 days before the end of the filing period
Companies linked to STERIGENICS BELGIUM (FLEURUS)
Parent and group
Insights on STERIGENICS BELGIUM (FLEURUS)
STERIGENICS BELGIUM (FLEURUS) has existed since 1990. Turnover grew from €8.2m in 2019 to €18.4m in 2025.
Turnover has grown every year since 2019.
NELSON LABS holds all the shares.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about STERIGENICS BELGIUM (FLEURUS)
- What is the company number of STERIGENICS BELGIUM (FLEURUS)?
- The company number of STERIGENICS BELGIUM (FLEURUS) is 0442.042.064. The VAT number is the same number with BE in front: BE 0442.042.064.
- Where is STERIGENICS BELGIUM (FLEURUS) based?
- The registered office is at Avenue de l'Espérance 17, 6220 Fleurus.Company details
- What does STERIGENICS BELGIUM (FLEURUS) do?
- According to the KBO register, the main activity is office administrative, office support and other business support activities (NACE 82920).
- What is the legal form of STERIGENICS BELGIUM (FLEURUS)?
- STERIGENICS BELGIUM (FLEURUS) is a private limited company (BV).
- When was STERIGENICS BELGIUM (FLEURUS) founded?
- STERIGENICS BELGIUM (FLEURUS) was founded on 26-11-1990.
- Is STERIGENICS BELGIUM (FLEURUS) still active?
- Yes, STERIGENICS BELGIUM (FLEURUS) is an active enterprise in the KBO register.
- How many employees does STERIGENICS BELGIUM (FLEURUS) have?
- STERIGENICS BELGIUM (FLEURUS) had an average of 45.7 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does STERIGENICS BELGIUM (FLEURUS) fall under?
- In its 2025 annual accounts, STERIGENICS BELGIUM (FLEURUS) states joint committees 116 (Chemical industry) and 207 (White-collar workers in the chemical industry).
- What is the turnover of STERIGENICS BELGIUM (FLEURUS)?
- The turnover of STERIGENICS BELGIUM (FLEURUS) was €18.4m in financial year 2025, according to the filed annual accounts.
- Is STERIGENICS BELGIUM (FLEURUS) profitable?
- In financial year 2025, STERIGENICS BELGIUM (FLEURUS) made a profit of €6.1m.
- Where can I find the annual accounts of STERIGENICS BELGIUM (FLEURUS)?
- STERIGENICS BELGIUM (FLEURUS) filed 35 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of STERIGENICS BELGIUM (FLEURUS) due?
- STERIGENICS BELGIUM (FLEURUS) must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence See whether the workforce is growing and whether people stay.Employer check Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See the other companies in the same group.STERIGENICS · 3 companies
See how customers, suppliers and banks see your own company and what to improve first.